Mahindra Manulife Multi Cap Fund Regular Plan Growth
- Multi-Cap
- Equity
- Very High Risk
Explore On
Rating:
4
Key Metrics
Aum
₹5,660.85 Cr
Expense Ratio
1.80%
Exit Load
1.00%
Min. Investment
₹1,000.00
Min. SIP
₹500.00
Launch Date
11 May 2017
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +2.33% | -- |
| 3 Months | -0.98% | -- |
| 6 Months | -1.07% | -- |
| 1 Year | +7.28% | +7.28% |
| 2 Years | -- | +8.48% |
| 3 Years | +71.23% | +19.64% |
| 5 Years | +119.84% | +17.06% |
| Since Launch | +258.73% | +15.25% |
Holdings as on 13 May 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Glenmark Pharmaceuticals | 210.83 | 3.72 |
| Larsen & Toubro Ltd | 184.48 | 3.26 |
| Divi's Laboratories | 169.49 | 2.99 |
| UltraTech Cement | 134.32 | 2.37 |
| Polycab India | 132.08 | 2.33 |
| APL Apollo Tubes Ltd | 125.94 | 2.22 |
| Indus Towers | 122.52 | 2.16 |
| Eternal | 115.82 | 2.05 |
| Reliance Industries | 110.88 | 1.96 |
| Laurus Labs | 109.20 | 1.93 |
Morning Star Rating
Rating:
4
Risk
Return
Risk & Volitility
0.82
Sharpe Ratio
16.84%
Std. Deviation
4.51%
Tracking Error
5.10%
Alpha
0.96
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| Mahindra Manulife Multi Cap Fund Regular Plan Growth | +7.28% | +19.64% | +17.06% |
| Aditya Birla Sun Life Multi-Cap Fund Regular Growth | +3.87% | +15.09% | +13.95% |
| Quant Multi Cap Fund Growth | +1.87% | +12.2% | +12.18% |
| HSBC Multi Cap Fund Regular Growth | +6.01% | +20.93% | -- |
| Canara Robeco Multi Cap Fund Regular Growth | +1.97% | -- | -- |
Results are calculated on CAGR basis
About Fund
The investment objective of the Scheme is to provide medium to long term capital appreciation through appropriate diversification and taking low risk on business quality. The diversified portfolio would predominantly consist of equity and equity related securities including derivatives.
The Mahindra Manulife Multi Cap Fund Regular Plan Growth has an AUM of 5660.85 crores & has delivered CAGR of 17.06 in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.80%. The minimum investment in Mahindra Manulife Multi Cap Fund Regular Plan Growth is Rs 1000 and the minimum SIP is Rs 500.
As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.
The fund has a present cash holding of %. The top holdings of the fund include Glenmark Pharmaceuticals, Larsen & Toubro Ltd, Divi's Laboratories, UltraTech Cement.
The major sectors where the fund is invested are Biotechnology & Drugs, Regional Banks, Investment Services, Software & Programming.
Some of the similar funds are Mahindra Manulife Multi Cap Fund Regular Plan Growth, Aditya Birla Sun Life Multi-Cap Fund Regular Growth, Quant Multi Cap Fund Growth, HSBC Multi Cap Fund Regular Growth, Canara Robeco Multi Cap Fund Regular Growth. Mahindra Manulife Multi Cap Fund Regular Plan Growth has a sharpe ratio of 0.82 & a standard deviation of 16.84%.
FAQs
According to the morning star rating Mahindra Manulife Multi Cap Fund Regular Plan Growth has a Medium risk & Exceptional return.
Mahindra Manulife Multi Cap Fund Regular Plan Growth is managed by Fatema Pacha,Vishal Jajoo.
The expense ratio of Mahindra Manulife Multi Cap Fund Regular Plan Growth is 1.80%.
The 5 year annualized return on Mahindra Manulife Multi Cap Fund Regular Plan Growth is 17.06% & it has generated 7.28% in the last 1 year.
The minimum investment in Mahindra Manulife Multi Cap Fund Regular Plan Growth is 1000 Rs.
Mahindra Manulife Multi Cap Fund Regular Plan Growth has an AUM of 5660.85 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.